Loughrea-based Chanelle Pharma, a global pharmaceutical leader in human and animal health, has announced the appointment of Michael Burke as Chief Financial Officer and Member of the Board of Directors.
The appointment follows a comprehensive international search process and marks a significant step in the company’s strategic growth plan under its ownership by Exponent.
Mr. Burke brings over two decades of experience steering global finance functions within the healthcare, consumer goods, and logistics industries. Throughout his career, he has held senior executive positions at world-class organisations, including Johnson & Johnson, Unilever, Coca-Cola, Kerry Group, and DB Schenker.
“Michael’s appointment comes at a transformative time for Chanelle Pharma,” said Angelo Gatto, Chief Executive Officer and Board Member at Chanelle Pharma.
“Michael brings extensiveexperience, including high-growth turnarounds and successful transformations, which perfectly matches Chanelle’s priorities today,” he said.
While Michael shares a surname with the company’s founder, he has no family connection to the Burke family; his selection was the result of a rigorous, independent recruitment process focused on securing world-class leadership for the next stage of the company’s evolution.
As CFO, Mr. Burke will oversee all aspects of Chanelle Pharma’s financial strategy, supporting the company’s mission to increase its global footprint and invest in high-growth pharmaceutical categories.
“I am honoured to join Chanelle Pharma at such an inflection point,” said Michael Burke. “The company has a rich heritage of Irish innovation and a formidable reputation on the global stage. I look forward to working with the leadership team and Exponent to build on this foundation and drive sustainable growth for our stakeholders.”
